tacrolimus extended-release capsules

FDA Drug Profile — tacrolimus, ASTAGRAF XL

tacrolimus extended-release capsules is listed in the FDA National Drug Code directory with 6 NDC codes, marketed under brand names including tacrolimus, ASTAGRAF XL. Available dosage form: capsule, coated, extended release.

Drug details

Generic Name
tacrolimus extended-release capsules
Brand Names
tacrolimus, ASTAGRAF XL
Application Number
ANDA215012
Sponsor
Chengdu Suncadia Medicine Co., Ltd.
NDC Codes
6
Dosage Forms
CAPSULE, COATED, EXTENDED RELEASE
Routes
ORAL
Active Ingredients
TACROLIMUS

Indications and Usage

1 INDICATIONS AND USAGE ASTAGRAF XL ® is indicated for the prophylaxis of organ rejection in kidney transplant patients in combination with other immunosuppressants in adult and pediatric patients who can swallow capsules intact [see Use in Specific Populations ( 8.4 ) and Clinical Studies ( 14.1 ), ( 14.2 )]. ASTAGRAF XL is a calcineurin-inhibitor immunosuppressant indicated for the prophylaxis of organ rejection in kidney transplant patients in combination with other immunosuppressants in adult and pediatric patients who can swallow capsules intact. ( 1 , 8.4 , 14.1 , 14.2 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.